Skip to content

We asked Google Bard to make a $1,000 stocks portfolio

We asked Google Bard to make a $1,000 stocks portfolio
Jordan Major

The resounding success of OpenAI’s LLM ChatGPT has sparked a fervent era of artificial intelligence (AI) enthusiasm, setting off a competitive frenzy among established tech titans to introduce their own cutting-edge AI offerings. 

In the midst of this technological race, Google Bard, the brainchild of Alphabet (NASDAQ: GOOGL), has taken the spotlight as a commanding force in the realm of generative AI. Boasting an impressive repertoire of capabilities, Google Bard’s prowess extends to the realm of predicting forthcoming trends within the financial markets, drawing the rapt attention of discerning stock investors.

Against this backdrop, on August 7, Finbold turned to Bard for insights, seeking to construct a meticulously curated stock portfolio with a modest $1,000 budget. Notably, Bard’s choice leaned towards a collection of five elite blue-chip stocks, including none other than Google itself.

It’s worth highlighting that each of these five chosen stocks—Apple (NASDAQ: AAPL), Microsoft (NASDAQ: MSFT), (NASDAQ: AMZN), Alphabet, and (NASDAQ: NFLX)—stands as a prominent player within the respective tech sector. Significantly, Bard proposes allocating the majority of the $1,000 portfolio budget to Apple, constituting a quarter of the total, while allocating the smallest portion of $100 each to Google and Netflix stocks.

Google Bard’s original $1,000 portfolio. Source: Bard

Bard picks a diversified portfolio

Highlighted by Finbold’s analysis, the stock portfolio in focus reveals a significant tilt toward the dynamic tech sector. Noteworthy, Bard acknowledges that this tilt might give rise to concerns for those in pursuit of a finely diversified investment array. 

Given the inherent volatility within the tech domain, there looms a plausible scenario wherein portfolio value could undergo a setback should the tech sector encounter a downturn. Bard acknowledged, “This could be a concern if you are looking for a well-diversified portfolio.”

“To improve the diversification of this portfolio, you could consider adding some stocks from other sectors, such as healthcare, finance, or consumer staples. You could also consider adding some bonds to your portfolio, which would help to reduce your risk.”

Bard’s revamped $1,000 portfolio. Source: Bard

The revamped portfolio model showcases distinct inclusions. Procter & Gamble is a global stalwart within consumer staples. Renowned for its mastery across categories spanning laundry essentials, oral care, and infant products, 

Johnson & Johnson (NYSE: JNJ) is a titan within the global healthcare panorama. Its dominance extends across pharmaceuticals, medical apparatus, and consumer health merchandise, thus imparting a reassuring stabilizing effect.

Rounding off this trinity is Walmart (NYSE: WMT), an unequivocal trailblazer in the realm of retail. Boasting an extensive network of brick-and-mortar establishments coupled with a robust digital presence.

Buy stocks now with Interactive Brokers – the most advanced investment platform


Disclaimer: The content on this site should not be considered investment advice. Investing is speculative. When investing, your capital is at risk.

Best Crypto Exchange for Intermediate Traders and Investors

  • Invest in cryptocurrencies and 3,000+ other assets including stocks and precious metals.

  • 0% commission on stocks - buy in bulk or just a fraction from as little as $10. Other fees apply. For more information, visit etoro.com/trading/fees.

  • Copy top-performing traders in real time, automatically.

  • eToro USA is registered with FINRA for securities trading.

30+ million Users
Securities trading offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. Finbold.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD

Read Next:

Finance Digest

By subscribing you agree with Finbold T&C’s & Privacy Policy

Related posts

Sign Up

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

Already have an account? Sign In

Services

Disclaimer: The information on this website is for general informational and educational purposes only and does not constitute financial, legal, tax, or investment advice. This site does not make any financial promotions, and all content is strictly informational. By using this site, you agree to our full disclaimer and terms of use. For more information, please read our complete Global Disclaimer.